PRECISIONscientia
PRECISIONscientia, a part of Precision Medicine Group since 2018, specializes in rare diseases, cell and gene therapy, and immuno-oncology, supporting over 90 biotech and pharma clients with a wide range of marketing, medical affairs, and training services.
Company History
PRECISIONscientia joined Precision Medicine Group in 2018, marking a significant milestone in its growth and development. Since then, the company has established a robust presence with offices in Philadelphia, Boston, and the United Kingdom. An important expansion occurred when Precision Value & Health acquired Makara Health, enhancing the company's communications capabilities in Europe.
Specialties and Services
PRECISIONscientia specializes in rare disease, cell and gene therapy, and immuno-oncology. It provides an array of services including marketing, medical affairs, KOL (Key Opinion Leader) Data Solutions, and training, learning, and development. In marketing, services range from commercialization strategy to digital marketing tactics. Medical affairs services include scientific communications and competitive intelligence. KOL Data Solutions offer tools like digital opinion leader mapping and engagement tracking, while training services cover instructional design and multimedia training innovations.
Therapies and Disease Areas Supported
As of 2020, PRECISIONscientia supports over 45 rare diseases, and in 2021, it contributed to over 15 cell and gene therapy products. The company supports more than 185 therapies across 145 disease states, reflecting its extensive engagement in the biotech and pharma sectors. Notably, it launched the first oral MS product in 2010 and the first CAR-T product in 2017.
Client Engagement and Retention
PRECISIONscientia provides services to over 90 biotech and pharma clients with an impressive average client retention rate exceeding 5 years, significantly higher than the industry average of 3 years. This high retention rate underscores the company's commitment to delivering consistent, high-quality services that meet the evolving needs of its clients.
Recognition and Employee Base
The company employs over 240 individuals, fostering a supportive and dynamic workplace environment. PRECISIONscientia's commitment to its employees and corporate culture has been recognized by The Business Journal, which has named it a Best Places to Work for the fourth consecutive year in 2023. This recognition reflects the company's ongoing efforts to maintain a positive and engaging workplace.